Horizons Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$311K Hold
338
0.2% 53
2025
Q4
$363K Hold
338
0.24% 51
2025
Q3
$258K Hold
338
0.18% 57
2025
Q2
$263K Hold
338
0.19% 60
2025
Q1
$279K Hold
338
0.21% 55
2024
Q4
$261K Hold
338
0.2% 57
2024
Q3
$299K Hold
338
0.23% 53
2024
Q2
$290K Hold
338
0.23% 55
2024
Q1
$197K Hold
338
0.13% 61
2023
Q4
$197K Buy
338
+329
+3,656% +$192K 0.13% 61
2023
Q3
$4.83K Hold
9
﹤0.01% 150
2023
Q2
$4.22K Buy
+9
New +$3.77K ﹤0.01% 177

Other funds holding LLY

Horizons Wealth Management's LLY Position: Q1 2026 in Review

Horizons Wealth Management held its Eli Lilly (LLY) position steady in Q1 2026 at 338 shares worth $311K. The position accounts for 0.2% of the portfolio, ranked #53.

Horizons Wealth Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $363K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Horizons Wealth Management held 338 shares of Eli Lilly worth $311K as of Q1 2026.
  • Horizons Wealth Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.2% of Horizons Wealth Management's portfolio in Q1 2026, its #53 holding.
  • Horizons Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Horizons Wealth Management's Eli Lilly position peaked at $363K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Horizons Wealth Management's 13F filing for Q1 2026, filed 2 Apr 2026.